SHANGHAI, China I April 2, 2025 I Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced its novel B7-H3-targeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback